Genetic Risk Score for Type 2 Diabetes and Traits Related to Glucose-Insulin Homeostasis in Youth: The Exploring Perinatal Outcomes Among Children (EPOCH) Study
posted on 2021-07-13, 15:00authored byMaggie A. Stanislawski, Elizabeth Litkowski, Sridharan Raghavan, Kylie K. Harrall, Jessica Shaw, Deborah H. Glueck, Ethan M. Lange, Dana Dabelea, Leslie A. Lange
Objective: The metabolic phenotype of youth-onset type 2
diabetes (T2D) differs from that of adult-onset T2D, but little is known about
genetic contributions. We aimed to evaluate the association between a T2D
genetic risk score (GRS) and traits related to glucose-insulin homeostasis among
healthy youth. Research Design and Methods: We used data from 356 youth (mean age 16.7 years, 50%
female) in the EPOCH cohort to calculate a standardized weighted GRS based on
271 single nucleotide
polymorphisms (SNPs) associated with T2D in adults. We used linear regression to assess
associations of the GRS with log-transformed fasting glucose, 2-hour glucose, homeostasis
model of insulin resistance
(HOMA-IR), oral disposition index, and insulinogenic index adjusted for age,
sex, body mass index (BMI) z-score, in utero exposure to maternal
diabetes, and genetic principal components. We also evaluated effect
modification by BMI z-score, in utero exposure to maternal diabetes and
ethnicity. Results: Higher weighted GRS was associated with lower oral disposition index (b=-0.11; 95% CI: -0.19, -0.02) and insulinogenic index (b=-0.08; 95% CI: -0.17, -0.001), but not with fasting
glucose (b=0.01; 95% CI: -0.01, 0.02), 2-hour glucose
(b=0.03; 95% CI: -0.0004, 0.06), or HOMA-IR
(b=0.02; 95% CI: -0.04, 0.07). BMI
z-score and in utero exposure to maternal diabetes increased the effect
of the GRS on glucose levels. Conclusions: Our results suggest that T2D genetic risk factors
established in adults are relevant to glucose-insulin homeostasis in youth and that maintaining a
healthy weight may be particularly important for youth with high genetic risk
for T2D.
Funding
This work was funded by the National Institute of Diabetes, Digestive and Kidney Disease (NIDDK) grant no. R01-DK068001. SR is supported by Award #P30DK116073 from the National Institute of Diabetes and Digestive and Kidney Diseases of the US National Institutes of Health, and by the Boettcher Foundation.